Skip to main content
Fig. 2 | Journal of Translational Medicine

Fig. 2

From: FGFR1 expression defines clinically distinct subtypes in pancreatic cancer

Fig. 2

Immunohistochemistry and Kaplan–Meier survival analysis of FGFR1 in the validation cohort of 205 pancreatic cancer patients. a, b Represent immunohistochemistry results of FGFR1-positive and -negative cases, respectively. c Overall survival of pancreatic cancer patients in the discovery cohort with high and low FGFR1 (c). FGFR: fibroblast growth factor receptor

Back to article page